INTU
58
-3
AIV
64
4
SLB
52
-3
MNST
45
-21
KLAC
38
-6
ADP
65
-3
KEY
43
-3
TSCO
44
-4
RCL
83
-2
SO
57
6
TROW
47
-6
ADM
28
3
NI
72
4
NEE
54
7
BBY
52
6
HBI
58
3
VRSK
68
-12
COST
57
-6
CAT
59
-2
PYPL
52
-2
INTU
58
-3
AIV
64
4
SLB
52
-3
MNST
45
-21
KLAC
38
-6
ADP
65
-3
KEY
43
-3
TSCO
44
-4
RCL
83
-2
SO
57
6
TROW
47
-6
ADM
28
3
NI
72
4
NEE
54
7
BBY
52
6
HBI
58
3
VRSK
68
-12
COST
57
-6
CAT
59
-2
PYPL
52
-2
Financhill
Back

Sparta Commercial Services Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

SRCO
Sparta Commercial Services

Last Price:
0.28
Seasonality Move:
30.27%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
Sparta Commercial Services (SRCO) is a Sell

Is Sparta Commercial Services a Buy, Sell or Hold?

  • The current Sparta Commercial Services [SRCO] share price is $0.28. The Score for SRCO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SRCO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRCO Stock Price Chart

What is Sparta Commercial Services's stock price today?

  • The Sparta Commercial Services share price today is $0.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRCO is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SRCO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: -13442 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.28 - 0.32) Sell
Bollinger Bands (100): (0.22 - 0.4) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SRCO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.3 Sell
20-day SMA: 0.3 Sell
50-day SMA: 0.34 Sell
200-day SMA: 0.21 Buy
8-day EMA: 0.29 Sell
20-day EMA: 0.31 Sell
50-day EMA: 0.32 Sell
200-day EMA: 0.24 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Sparta Commercial Services Earnings Growth & SRCO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Sparta Commercial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):